Breaks Categories: News

TuesdayJan 08, 2019 10:08 am

NetworkNewsBreaks – Canopy Rivers Inc. (TSX.V: RIV) (OTC: CNPOF) Enters Technology-Focused Cannabis Vertical via Investment in Headset, Inc.; Secures $80M Financial Development for PharmHouse

Canopy Rivers (TSX.V: RIV) (OTC: CNPOF) this morning announced its completion of an equity investment in Headset, Inc., a data and analytics service provider for the cannabis industry. Representing its first entry into a technology-focused cannabis vertical, Canopy Rivers subscribed for CAD $4,084,500 of Series A Preferred Shares in Headset. In addition, the company recently announced that its 49 percent-owned joint venture PharmHouse Inc. has entered into a syndicated credit facility with the Bank of Montreal (“BMO”), as agent and lead lender, and with Canadian Imperial Bank of Commerce and Concentra Bank as lenders. According to the update, under the…

Continue Reading

TuesdayJan 08, 2019 9:29 am

NetworkNewsBreaks – CytoDyn Inc. (CYDY) to Present at Biotech Showcase Conference

Biotechnology company CytoDyn (OTCQB: CYDY) this morning announced that it will be presenting at the Biotech Showcase at the Hilton San Francisco Union Square in San Francisco, California on January 9, 2019 at 10:30 AM PT. An update on the company’s clinical development programs and objectives for leronlimab (PRO 140) will be co-presented by president and CEO Nader Pourhassan, Ph.D. and chief medical officer and vice chairman Richard G. Pestell, M.D., Ph.D., M.B.A., F.A.C.P., F.R.A.C.P. The presentation will provide insights regarding the company’s plans for 2019, including details on its first BLA submission of PRO 140 anticipated to occur during…

Continue Reading

TuesdayJan 08, 2019 8:30 am

NetworkNewsBreaks – Pacific Rim Cobalt Corp. (CSE: BOLT) (OTCQB: PCRCF) (XFRA: NXFE) Updates Shareholders with 2018 Milestones and 2019 Strategic Goals

Canada-based exploration company Pacific Rim Cobalt (CSE: BOLT) (OTCQB: PCRCF) (XFRA: NXFE) recently provided a shareholder update detailing the company’s 2018 milestones and growth initiatives, as well as strategic goals for 2019. According to the update, the company’s primary objectives for 2018 included exploration of its Cyclops Nickel-Cobalt Project, located in Jayapura Province, Indonesia. The company conducted extensive consultation with local stakeholders and regional government officials, resulting in overwhelming support for advancement of the Cyclops Project. In addition, in November of 2018, the company announced strong results from a mini-bulk sample at the project, bolstering Pacific Rim’s long-held views that…

Continue Reading

MondayJan 07, 2019 2:31 pm

NetworkNewsBreaks – Monaker Group, Inc. (NASDAQ: MKGI) Inks Contracts with Nine Additional Travel Partners Increasing Contracted Distributor Count to 24

Monaker Group (NASDAQ: MKGI), a technology leader in the travel and vacation rental markets, this morning announced its entrance into contracts with nine additional travel distributors to integrate and offer the company’s instantly-bookable vacation rentals through its established distribution channels. The new contracts bring Monaker’s business-to-business (“B2B”) travel distribution network total to twenty-four contracted distribution partners. Since being launched by the company in 2018, five of its contracted partners have gone live with its next-gen Monaker Booking Engine (“MBE”), with the remaining nineteen currently working to complete their integrations. “These twenty-four distributor partners represent hundreds of downstream travel companies, website,…

Continue Reading

MondayJan 07, 2019 11:34 am

NetworkNewsBreaks – SinglePoint, Inc. (SING) Invests in TorusMed Inc. for Lab-Based Development of CBD Cell Cultures

Technology and investment company SinglePoint (OTCQB: SING) this morning announced its investment in TorusMed Inc. to develop cannabidiol (“CBD”) cell cultures from industrial hemp. According to the update, the ultimate goal of the project is the development of pharmaceutical grade CBD that is cultivated in lab settings, potentially changing the way industrial hemp and CBD are manufactured, reducing time, cost and resources while increasing consistency, safety and scalability. The project’s specific aim is to develop optimal protocols for mass CBD production from cell cultures of industrial hemp, which offers several advantages as compared to open-field farm cultivation including, but not…

Continue Reading

MondayJan 07, 2019 10:39 am

NetworkNewsBreaks – Pressure BioSciences Inc. (PBIO) Announces Eagerly-Anticipated Commercial Launch of Biopharmaceuticals Contract Services Business

Pressure BioSciences (OTCQB: PBIO), a leader in the development and sale of high pressure-based instruments, consumables, and related services for the global life sciences industry, this morning announced the commercial launch of its Biopharmaceuticals Contract Services Business. The eagerly-anticipated launch follows PBIO’s December 2017 acquisition of the assets of BaroFold, Inc., including patents, equipment, and other intellectual property relating to its unique, high pressure-based protein disaggregation and refolding platform. PBIO expects the technology platform to offer substantial improvement in the quality and costs of manufacturing protein therapeutics. “We are excited to announce the launch of our Biopharmaceutical Contract Services Business…

Continue Reading

MondayJan 07, 2019 9:57 am

NetworkNewsBreaks – CytoDyn Inc. (CYDY) Names Richard G. Pestell, M.D., Ph.D. as Board Vice Chairman, Expanding Leadership Role in Advancement of Company Initiatives

Biotechnology company CytoDyn (OTCQB: CYDY) today announced the election of its Chief Medical Officer and Director Richard G. Pestell, M.D., Ph.D., M.B.A., F.A.C.P., F.R.A.C.P. to the additional position of vice chairman of the board of directors. In this added role Pestell, an internationally renowned clinician and cancer researcher and defining force in CCR5 antagonist research, will advance and accelerate CYDY’s initiatives in seeking non-dilutive licensing opportunities in cancer and immunology. “We are honored to have Dr. Pestell serve as our Vice Chairman,” CytoDyn President and Chief Executive Officer Nader Pourhassan stated in the news release.  “He is a world renowned…

Continue Reading

MondayJan 07, 2019 9:47 am

NetworkNewsBreaks – Foresight Autonomous Holdings Ltd.’s (NASDAQ: FRSX) (TASE: FRSX) Eye-Net Mobile Collaborates with Leading Israeli Cellular Provider in Successful Initial Integration

Automotive technology innovator Foresight Autonomous Holdings (NASDAQ: FRSX) (TASE: FRSX) this morning announced that its wholly owned subsidiary Eye-Net Mobile Ltd. has successfully installed its Eye-Net application’s communication layer on the data center of a leading Israeli cellular provider. A V2X cellular-based accident prevention solution, Eye-Net is designed to provide real-time pre-collision alerts to pedestrians and vehicles through smartphones and reliance on existing cellular networks. Collaboration with the cellular provider and leveraging its technological expertise and engineering design assistance may improve Eye-Net’s efficiency, allowing for more accurate alerts, most significant with the application’s deployment across a large number of mobile…

Continue Reading

FridayJan 04, 2019 9:58 am

NetworkNewsBreaks – Sunniva Inc. (CSE: SNN) (OTCQX: SNNVF) Secures Over $2.4M in Initial Cannabis Product Sales in California

Vertically integrated cannabis company Sunniva (CSE: SNN) (OTCQX: SNNVF) this morning announced that it has secured more than USD $2.4 million in future sales of Sunniva branded cannabis products, to be completed in the first four months of 2019. Achieved through one of the company’s existing retail relationships, this marks Sunniva’s first cannabis product sales in the state of California, and it anticipates securing additional sales contracts in the near future. Sunniva’s current product inventory is estimated at a value in excess of USD $5 million and consists of ultrapure cannabis distillate, premium concentrates and flower. The company intends to…

Continue Reading

FridayJan 04, 2019 9:28 am

NetworkNewsBreaks – Canopy Rivers Inc. (TSX.V: RIV) (OTC: CNPOF) Retains Hybrid Financial Ltd. for IR Services

Canopy Rivers (TSX.V: RIV) (OTC: CNPOF) recently announced that it has retained Hybrid Financial Ltd., a marketing and retail distribution services company, to provide certain investor relations (“IR”) services for an initial term of six months. Canopy Rivers will pay Hybrid a monthly fee of CAD $14,000, and has granted Hybrid options to purchase up to 120,000 shares of the company at a price of $3.50 per share. Starting three months after the grant, the options shall vest in quarterly increments and will expire within 12 months of the grant, except for the final tranche, which expires three months following…

Continue Reading